bioRxiv Science⌕ Search

Biology subjects

Segschneider, M.

Publications and source records attributed to Segschneider, M..

2 recordsLinked to original sources

Mapping human microglial morphological diversity via handcrafted and deep learning-derived image features

Microglia play critical roles in brain health and disease by adopting a spectrum of dynamic activation states. However, capturing this continuous heterogeneity in a scalable way remains a major challenge. To address this, we developed an imaging and data analysis framework to map the activation landscape of human iPSC-derived microglia (iMG) at single-cell resolution. We combined high-content imaging using two complementary strategies: a hypothesis-driven immunofluorescence (IF) panel targeting key activation markers (NF-{kappa}B, ASC, CD45) and a discovery-oriented, pan-morphological Cell Painting (CP) assay. Diverse phenotypes were captured through handcrafted and representation learning-based features. To classify cells, we applied Gaussian Mixture Models (GMMs) to image-derived features, enabling soft probabilistic assignments that capture transitional states between phenotypes. Compared to graph-based methods like the Leiden algorithm, GMMs provided comparable classification performance while offering a more nuanced and biologically interpretable view of microglial heterogeneity. We demonstrate that deep learning features from the targeted IF panel are most powerful, achieving high classification accuracy and strong correlation with biological states such as functional NLRP3 inflammasome activation. Our model system provides a robust and scalable platform for quantifying microglial heterogeneity, offering a new tool to identify novel disease-associated states and compounds that precisely modulate microglial phenotypes for therapeutic discovery.

neuroscience↗

Machine learning-aided multidimensional phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons

Combining multiple Parkinsons disease (PD) relevant cellular phenotypes might increase the accuracy of midbrain dopaminergic (mDA) in vitro models. We differentiated patient-derived induced pluripotent stem cells (iPSCs) with a LRRK2 G2019S mutation, isogenic control and genetically unrelated iPSCs into mDA neurons. Using automated fluorescence microscopy in 384-well plate format, we identified elevated levels of -synuclein and Serine 129 phosphorylation (pS129), reduced dendritic complexity, and mitochondrial dysfunction. Next, we measured additional image-based phenotypes and used machine learning (ML) to accurately classify mDA neurons according to their genotype. Additionally, we show that chemical compound treatments, targeting LRRK2 kinase activity or -synuclein levels, are detectable when using ML classification based on multiple image-based phenotypes. We validated our approach using a second isogenic patient derived SNCA gene triplication mDA neuronal model. This phenotyping and classification strategy improves the exploitability of mDA neurons for disease modelling and the identification of novel PD drug targets.

neuroscience↗